U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 84

1.
ENTPD1 (CD39) and NT5E (CD73) expression in human glioblastoma: an in silico analysis
Elizandra Braganhol, Guilherme Pamplona Bueno de Andrade, Guilherme Tomasi Santos, Marco Antônio Stefani
Purinergic Signal. 2024 Jun; 20(3): 285–289. Published online 2023 Jul 4. doi: 10.1007/s11302-023-09951-0
PMCID:
PMC11189379
AbstractArticlePDF–423K
2.
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes
Alessia Parodi, Florinda Battaglia, Francesca Kalli, Francesca Ferrera, Giuseppina Conteduca, Samuele Tardito, Silvia Stringara, Federico Ivaldi, Simone Negrini, Giacomo Borgonovo, Alchiede Simonato, Paolo Traverso, Giorgio Carmignani, Daniela Fenoglio, Gilberto Filaci
Cancer Immunol Immunother. 2013 May; 62(5): 851–862. Published online 2013 Jan 29. doi: 10.1007/s00262-013-1392-z
PMCID:
PMC11029015
AbstractArticlePDF–568K
3.
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
Sebastian F. M. Häusler, Itsaso Montalbán del Barrio, Jenny Strohschein, P. Anoop Chandran, Jörg B. Engel, Arnd Hönig, Monika Ossadnik, Evi Horn, Birgitt Fischer, Mathias Krockenberger, Stefan Heuer, Ahmed Adel Seida, Markus Junker, Hermann Kneitz, Doris Kloor, Karl-Norbert Klotz, Johannes Dietl, Jörg Wischhusen
Cancer Immunol Immunother. 2011 Oct; 60(10): 1405–1418. Published online 2011 Jun 3. doi: 10.1007/s00262-011-1040-4
PMCID:
PMC11028787
AbstractArticlePDF–2.1M
4.
Human plasmacytoid dendritic cells express the functional purinergic halo (CD39/CD73)
S. A. Sosa-Luis, W. J. Ríos-Ríos, A. Almaraz-Arreortua, M. A. Romero-Tlalolini, S. R. Aguilar-Ruiz, R. Valle-Ríos, C. Sánchez-Torres, H. Torres-Aguilar
Purinergic Signal. 2024 Feb; 20(1): 73–82. Published online 2023 Apr 14. doi: 10.1007/s11302-023-09940-3
PMCID:
PMC10828132
AbstractArticlePDF–1.0M
5.
Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response
María Angels Ortiz, Cesar Diaz-Torné, Juan Jose De Agustin, Paula Estrada, Delia Reina, María Victoria Hernandez, Hye Sang, Carlos Zamora, Elisabet Cantó, Hector Corominas, Silvia Vidal
Biomolecules. 2024 Jan; 14(1): 1. Published online 2023 Dec 19. doi: 10.3390/biom14010001
PMCID:
PMC10813161
AbstractArticlePDF–3.1M
6.
Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19
Alaa Elsaghir, Ehsan M. W. El-Sabaa, Asmaa M. Zahran, Sahar A. Mandour, Eman H. Salama, Sahar Aboulfotuh, Reham M. El-Morshedy, Stefania Tocci, Ahmed Mohamed Mandour, Wael Esmat Ali, Lobna Abdel-Wahid, Ibrahim M. Sayed, Mohamed A. El-Mokhtar
Int J Mol Sci. 2023 Dec; 24(24): 17614. Published online 2023 Dec 18. doi: 10.3390/ijms242417614
PMCID:
PMC10744088
AbstractArticlePDF–2.6M
7.
Cancer CD39 drives metabolic adaption and mal-differentiation of CD4+ T cells in patients with non-small-cell lung cancer
Ying Wang, Mengdi Liu, Lei Zhang, Xiyu Liu, Huiyan Ji, Yan Wang, Jun Gui, Yan Yue, Zhenke Wen
Cell Death Dis. 2023 Dec; 14(12): 804. Published online 2023 Dec 8. doi: 10.1038/s41419-023-06336-4
PMCID:
PMC10703826
AbstractArticlePDF–3.8M
8.
A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance
Ankita Mitra, Brian Thompson, Ann Strange, Carol M. Amato, Melinda Vassallo, Igor Dolgalev, Jonathan Hester-McCullough, Tomoaki Muramatsu, Diana Kimono, Amrutesh S. Puranik, Jeffrey S. Weber, David Woods
Clin Cancer Res. Author manuscript; available in PMC 2024 Apr 13.
Published in final edited form as: Clin Cancer Res. 2023 Oct 13; 29(20): 4242–4255. doi: 10.1158/1078-0432.CCR-23-0653
PMCID:
PMC10592215
AbstractArticlePDF–3.0M
9.
Human soluble CD39 displays substrate inhibition in a substrate-specific manner
Venkat M. K. Vadlamani, Kavinda K. J. Gunasinghe, Xavier W. Chee, Taufiq Rahman, Matthew T. Harper
Sci Rep. 2023; 13: 8958. Published online 2023 Jun 2. doi: 10.1038/s41598-023-36257-3
PMCID:
PMC10238538
AbstractArticlePDF–6.4M
10.
Biallelic variants in the ectonucleotidase ENTPD1 cause a complex neurodevelopmental disorder with intellectual disability, hypomyelination, and spastic paraplegia
Daniel G. Calame, Isabella Herman, Aren E. Marshall, Reza Maroofian, Karina Carvalho Donis, Jawid M. Fatih, Tadahiro Mitani, Haowei Du, Christopher M. Grochowski, Sergio Sousa, Somayeh Bakhtiari, Yoko A. Ito, Clarissa Rocca, Jill V. Hunter, V. Reid Sutton, Lisa T. Emrick, Kym M. Boycott, Alexander Lossos, Yakov Fellig, Eugenia Prus, Yosef Kalish, Vardiella Meiner, Manon Suerink, Claudia Ruivenkamp, Kayla Muirhead, Nebal W. Saadi, Maha S. Zaki, David L. Skidmore, Matthew Osmond, Thiago Oliveira Silva, Henry Houlden, David Murphy, Ehsan Ghayoorarimiani, Yalda Jamshidi, Asaad Ghanim Jaddoa, Homa Tajsharghi, Sheng Chih Jin, Zeynep Coban-Akdemir, Lorena Travaglini, Francesco Nicita, Shalini N. Jhangiani, Richard A. Gibbs, Jennifer E. Posey, Michael C. Kruer, Kristin D. Kernohan, Jonas A. Morales Saute, Adeline Vanderver, Davut Pehlivan, Dana Marafi, James R. Lupski
Ann Neurol. Author manuscript; available in PMC 2023 Aug 1.
Published in final edited form as: Ann Neurol. 2022 Aug; 92(2): 304–321. Published online 2022 May 28. doi: 10.1002/ana.26381
PMCID:
PMC10054521
AbstractArticlePDF–2.7M
11.
CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden
Jitske van den Bulk, Manon van der Ploeg, Marieke E Ijsselsteijn, Dina Ruano, Ruud van der Breggen, Rebekka Duhen, Koen C M J Peeters, Arantza Fariña-Sarasqueta, Els M E Verdegaal, Sjoerd H van der Burg, Thomas Duhen, Noel F C C de Miranda
J Immunother Cancer. 2023; 11(2): e005887. Published online 2023 Feb 15. doi: 10.1136/jitc-2022-005887
PMCID:
PMC9933759
AbstractArticlePDF–5.2M
12.
The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy
Xuan Jiang, Xiaofang Wu, Yuxi Xiao, Penglin Wang, Jiamian Zheng, Xiuli Wu, Zhenyi Jin
Front Immunol. 2023; 14: 1110325. Published online 2023 Jan 27. doi: 10.3389/fimmu.2023.1110325
PMCID:
PMC9911447
AbstractArticlePDF–1.5M
13.
Ectonucleoside triphosphate diphosphohydrolase-1 (CD39) impacts TGF-β1 responses: insights into cardiac fibrosis and function following myocardial infarction
Tatiana Novitskaya, Shamama Nishat, Roman Covarrubias, Debra G. Wheeler, Elena Chepurko, Oscar Bermeo-Blanco, Zhaobin Xu, Bradly Baer, Heng He, Stephanie N. Moore, Karen M. Dwyer, Peter J. Cowan, Yan Ru Su, Tarek S. Absi, Jonathan Schoenecker, Leon M. Bellan, Walter J. Koch, Shyam Bansal, Igor Feoktistov, Simon C. Robson, Erhe Gao, Richard J. Gumina
Am J Physiol Heart Circ Physiol. 2022 Dec 1; 323(6): H1244–H1261. Published online 2022 Oct 14. doi: 10.1152/ajpheart.00138.2022
PMCID:
PMC9722260
AbstractArticle
14.
Extracellular mitochondria drive CD8 T cell dysfunction in trauma by upregulating CD39
Shilpa Tiwari-Heckler, Ghee Rye Lee, James Harbison, Carola Ledderose, Eva Csizmadia, David Melton, Quanzhi Zhang, Wolfgang Junger, Guanqing Chen, Carl J Hauser, Leo E Otterbein, Maria Serena Longhi, Simon Christopher Robson
Thorax. Author manuscript; available in PMC 2023 Mar 1.
Published in final edited form as: Thorax. 2023 Feb; 78(2): 151–159. Published online 2022 May 25. doi: 10.1136/thoraxjnl-2021-218047
PMCID:
PMC9691787
AbstractArticlePDF–952K
15.
Assessment of CD39 expression in regulatory T‐cell subsets by disease severity in adult and juvenile COVID‐19 cases
Abdurrahman Simsek, Muhammed A. Kizmaz, Eren Cagan, Fatma Dombaz, Gulcin Tezcan, Ali Asan, H. Ibrahim Demir, S. Haldun Bal, Digdem Y. Ermis, Aslı G. Dilektaslı, Esra Kazak, E. Halis Akalin, H. Barbaros Oral, Ferah Budak
J Med Virol. 2022 May; 94(5): 2089–2101. Published online 2022 Jan 26. doi: 10.1002/jmv.27593
PMCID:
PMC9015412
AbstractArticlePDF–3.6M
16.
Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer
Pauline Weimer, Jasmin Wellbrock, Tabea Sturmheit, Leticia Oliveira-Ferrer, Yi Ding, Stephan Menzel, Marius Witt, Louisa Hell, Barbara Schmalfeldt, Carsten Bokemeyer, Walter Fiedler, Franziska Brauneck
Cells. 2022 Mar; 11(6): 964. Published online 2022 Mar 11. doi: 10.3390/cells11060964
PMCID:
PMC8946192
AbstractArticlePDF–3.0M
17.
Is the regulation by miRNAs of NTPDase1 and ecto-5’-nucleotidase genes involved with the different profiles of breast cancer subtypes?
Fernanda Cardoso da Silva, Angelo Borges de Melo Neto, Christina Aparecida Martins, Thaís Cunha de Sousa Cardoso, Matheus de Souza Gomes, Thaise Gonçalves de Araújo, Cristina Ribas Fürstenau
Purinergic Signal. 2022 Mar; 18(1): 123–133. Published online 2021 Nov 5. doi: 10.1007/s11302-021-09824-4
PMCID:
PMC8850496
AbstractArticlePDF–1.2M
18.
Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation
Elena Díaz-García, Sara García-Tovar, Enrique Alfaro, Ester Zamarrón, Alberto Mangas, Raúl Galera, José Juan Ruíz-Hernández, Jordi Solé-Violán, Carlos Rodríguez-Gallego, Ana Van-Den-Rym, Rebeca Pérez-de-Diego, Kapil Nanwani-Nanwani, Eduardo López-Collazo, Francisco García-Rio, Carolina Cubillos-Zapata
Front Immunol. 2022; 13: 847894. Published online 2022 Jan 31. doi: 10.3389/fimmu.2022.847894
PMCID:
PMC8841513
AbstractArticlePDF–3.9M
19.
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients
Angelica Macauda, Chiara Piredda, Alyssa I. Clay-Gilmour, Juan Sainz, Gabriele Buda, Miroslaw Markiewicz, Torben Barington, Elad Ziv, Michelle A.T. Hildebrandt, Alem A. Belachew, Judit Varkonyi, Witold Prejzner, Agnieszka Druzd-Sitek, John Spinelli, Niels Frost Andersen, Jonathan N. Hofmann, Marek Dudziński, Joaquin Martinez-Lopez, Elzbieta Iskierka-Jazdzewska, Roger L. Milne, Grzegorz Mazur, Graham G. Giles, Lene Hyldahl Ebbesen, Marcin Rymko, Krzysztof Jamroziak, Edyta Subocz, Rui Manuel Reis, Ramon Garcia-Sanz, Anna Suska, Eva Kannik Haastrup, Daria Zawirska, Norbert Grzasko, Annette Juul Vangsted, Charles Dumontet, Marcin Kruszewski, Magdalena Dutka, Nicola J. Camp, Rosalie G. Waller, Waldemar Tomczak, Matteo Pelosini, Małgorzata Raźny, Herlander Marques, Niels Abildgaard, Marzena Wątek, Artur Jurczyszyn, Elizabeth E. Brown, Sonja Berndt, Aleksandra Butrym, Celine M. Vachon, Aaron D. Norman, Susan L. Slager, Federica Gemignani, Federico Canzian, Daniele Campa
Int J Cancer. Author manuscript; available in PMC 2022 Jan 20.
Published in final edited form as: Int J Cancer. 2021 Jul 15; 149(2): 327–336. Published online 2021 Mar 30. doi: 10.1002/ijc.33547
PMCID:
PMC8770990
AbstractArticlePDF–457K
20.
Favorable function of Ectonucleoside triphosphate diphosphohydrolase 1 high expression in thyroid carcinoma
Jun-hua Luo, Yun-hua Zhu, Cheng Xiang
Hereditas. 2021; 158: 33. Published online 2021 Aug 31. doi: 10.1186/s41065-021-00198-6
PMCID:
PMC8408975
AbstractArticlePDF–4.8M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center